Volume 8, Number 11—November 2002
THEME ISSUE
Tuberculosis Genotyping
Tuberculosis Genotyping Network, United States
Molecular Epidemiology of Multidrug-Resistant Tuberculosis, New York City, 1995–1997
Table 2
Clustered strain (n=234) |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Characteristics | W | W1 | H | AB | P | AU | C | P1 | Other | Unique RFLPa |
No. of patients | 59 | 7 | 18 | 14 | 13 | 6 | 5 | 4 | 27 | 81 |
No. of bands | 18 | 19 | 2 | 11 | 11 | 10 | 3 | 11 | 4–18 | 2–22 |
Known epidemiologic links | ||||||||||
Nosocomial | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Community | 4 | 1 | 2 | 7 | 1 | 2 | 0 | 0 | 1 | 5 |
Age (median, in yrs) | 41 | 41 | 37 | 42 | 43 | 40 | 37 | 37 | 41 | 42 |
Male | 41 | 3 | 7 | 7 | 7 | 4 | 4 | 3 | 17 | 49 |
Race/ethnicity | ||||||||||
Asian | 2 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 16 |
Hispanic | 18 | 2 | 10 | 1 | 3 | 1 | 3 | 2 | 9 | 24 |
Black, non-Hispanic | 25 | 1 | 6 | 12 | 9 | 1 | 1 | 2 | 15 | 31 |
White, non-Hispanic | 14 | 3 | 1 | 1 | 0 | 4 | 0 | 0 | 3 | 10 |
U.S.-born | 46 | 4 | 15 | 13 | 10 | 5 | 3 | 3 | 21 | 42 |
HIV positive | 42 | 1 | 14 | 10 | 4 | 4 | 3 | 1 | 17 | 29 |
History of— | ||||||||||
Homelessness | 6 | 0 | 1 | 8 | 3 | 0 | 2 | 0 | 2 | 5 |
Alcohol abuse | 11 | 1 | 1 | 3 | 4 | 0 | 0 | 0 | 5 | 9 |
Injection drug use | 9 | 0 | 2 | 6 | 0 | 1 | 0 | 1 | 5 | 8 |
Prior tuberculosis treatment | 0 | 0 | 1 | 0 | 1 | 1 | 2 | 0 | 5 | 12 |
Health-care worker | 4 | 3 | 1 | 0 | 1 | 0 | 1 | 0 | 2 | 2 |
Borough of residence | ||||||||||
Manhattan | 23 | 1 | 8 | 4 | 1 | 1 | 3 | 0 | 10 | 19 |
Bronx | 17 | 0 | 4 | 0 | 0 | 0 | 1 | 0 | 2 | 8 |
Brooklyn | 7 | 2 | 5 | 10 | 9 | 5 | 1 | 4 | 11 | 30 |
Queens | 12 | 4 | 1 | 0 | 3 | 0 | 0 | 0 | 4 | 23 |
Staten Island | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
aRFLP, restriction fragment length polymorphism.
Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.